Literature DB >> 23876627

Discussing the diagnosis of HPV-OSCC: common questions and answers.

Carole Fakhry1, Gypsyamber D'Souza2.   

Abstract

Human papillomavirus (HPV) is responsible for a rising proportion of oropharyngeal squamous cell cancers (OSCCs). HPV-positive OSCCs (HPV-OSCCs) are associated with oral HPV infection and sexual behavior. Patient questions regarding risk factors, prognosis and implications for past, present and future relationships often arise. This manuscript addresses frequently asked questions by patients with HPV-OSCC and their families. A framework for clinicians to address these conversations and the limitations of our present knowledge base is also presented.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Behavior; HPV; Oropharyngeal cancer; Patient counseling; Sexually transmitted infection

Mesh:

Substances:

Year:  2013        PMID: 23876627      PMCID: PMC4264664          DOI: 10.1016/j.oraloncology.2013.06.002

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  74 in total

1.  Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial.

Authors:  Diane M Harper; Eduardo L Franco; Cosette M Wheeler; Anna-Barbara Moscicki; Barbara Romanowski; Cecilia M Roteli-Martins; David Jenkins; Anne Schuind; Sue Ann Costa Clemens; Gary Dubin
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

2.  Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus.

Authors:  F Coutlée; A M Trottier; G Ghattas; R Leduc; E Toma; G Sanche; I Rodrigues; B Turmel; G Allaire; P Ghadirian
Journal:  Sex Transm Dis       Date:  1997-01       Impact factor: 2.830

Review 3.  Improving comprehension for cancer patients with low literacy skills: strategies for clinicians.

Authors:  C C Doak; L G Doak; G H Friedell; C D Meade
Journal:  CA Cancer J Clin       Date:  1998 May-Jun       Impact factor: 508.702

4.  National patterns in the treatment of smokers by physicians.

Authors:  A N Thorndike; N A Rigotti; R S Stafford; D E Singer
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

5.  Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies.

Authors:  R C Rose; C Lane; S Wilson; J A Suzich; E Rybicki; A L Williamson
Journal:  Vaccine       Date:  1999-04-23       Impact factor: 3.641

6.  Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.

Authors:  Kirsten McCaffery; Jo Waller; Sue Forrest; Louise Cadman; Anne Szarewski; Jane Wardle
Journal:  BJOG       Date:  2004-12       Impact factor: 6.531

7.  Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study.

Authors:  Peter V Chin-Hong; Eric Vittinghoff; Ross D Cranston; Susan Buchbinder; Daniel Cohen; Grant Colfax; Maria Da Costa; Teresa Darragh; Eileen Hess; Franklyn Judson; Beryl Koblin; Maria Madison; Joel M Palefsky
Journal:  J Infect Dis       Date:  2004-11-10       Impact factor: 5.226

8.  Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.

Authors:  J A Suzich; S J Ghim; F J Palmer-Hill; W I White; J K Tamura; J A Bell; J A Newsome; A B Jenson; R Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

9.  Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.

Authors:  G Y Ho; R D Burk; S Klein; A S Kadish; C J Chang; P Palan; J Basu; R Tachezy; R Lewis; S Romney
Journal:  J Natl Cancer Inst       Date:  1995-09-20       Impact factor: 13.506

10.  Psychological response to cervical screening.

Authors:  S Bell; M Porter; H Kitchener; C Fraser; P Fisher; E Mann
Journal:  Prev Med       Date:  1995-11       Impact factor: 4.018

View more
  21 in total

1.  Psychosocial implications.

Authors:  S Thavaraj; E Odell
Journal:  Br Dent J       Date:  2014-01       Impact factor: 1.626

2.  Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer.

Authors:  Anthony R Cillo; Cornelius H L Kürten; Tracy Tabib; Zengbiao Qi; Sayali Onkar; Ting Wang; Angen Liu; Umamaheswar Duvvuri; Seungwon Kim; Ryan J Soose; Steffi Oesterreich; Wei Chen; Robert Lafyatis; Tullia C Bruno; Robert L Ferris; Dario A A Vignali
Journal:  Immunity       Date:  2020-01-07       Impact factor: 31.745

Review 3.  Epidemiologic trends in head and neck cancer and aids in diagnosis.

Authors:  Nadarajah Vigneswaran; Michelle D Williams
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2014-05       Impact factor: 2.802

4.  Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners.

Authors:  Gypsyamber D'Souza; Neil D Gross; Sara I Pai; Robert Haddad; Karen S Anderson; Shirani Rajan; Jennifer Gerber; Maura L Gillison; Marshall R Posner
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

5.  Matted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Matthew E Spector; Mohannad Ibrahim; Carol R Bradford; Gregory T Wolf; Matthew H Stenmark; Francis P Worden; Jonathan B McHugh; Mark E Prince; Thomas Carey; Douglas B Chepeha; Avraham Eisbruch
Journal:  Head Neck       Date:  2015-07-15       Impact factor: 3.147

Review 6.  The role of sexual behavior in head and neck cancer: implications for prevention and therapy.

Authors:  Eleni Rettig; Ana Ponce Kiess; Carole Fakhry
Journal:  Expert Rev Anticancer Ther       Date:  2014-09-05       Impact factor: 4.512

Review 7.  Concurrent oropharyngeal squamous cell carcinomas in couples.

Authors:  Prashanth Panta; Mukund Seshadri
Journal:  Oral Oncol       Date:  2019-04-25       Impact factor: 5.972

8.  Detection of Human Papillomavirus 16-Specific IgG and IgM Antibodies in Patient Sera: A Potential Indicator of Oral Squamous Cell Carcinoma Risk Factor.

Authors:  Jesinda P Kerishnan; Subash C B Gopinath; Sia Bik Kai; Thean-Hock Tang; Helen Lee-Ching Ng; Zainal Ariff Abdul Rahman; Uda Hashim; Yeng Chen
Journal:  Int J Med Sci       Date:  2016-05-12       Impact factor: 3.738

9.  Discussing a diagnosis of human papillomavirus oropharyngeal cancer with patients: An exploratory qualitative study of health professionals.

Authors:  Rachael H Dodd; Laura A V Marlow; Jo Waller
Journal:  Head Neck       Date:  2015-05-22       Impact factor: 3.147

Review 10.  Human Papillomavirus and Head and Neck Cancer: Psychosocial Impact in Patients and Knowledge of the Link - A Systematic Review.

Authors:  R H Dodd; J Waller; L A V Marlow
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-03-18       Impact factor: 4.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.